A 70-year-old female with type 2 diabetes is brought to the clinic by her daughter, who states that her mother has been more drowsy and irritable than usual. This morning, she was found confused, diaphoretic, and unable to answer Questions clearly. The patient has a history of poor oral intake over the past 2 days and is currently taking glipizide. Vital signs show BP 130/82 mmHg HR 98 bpm RR 18 breaths/min Temp 97.8 Blood glucose is 42 mg/dL Based on these findings, which condition is the client most likely experiencing?

Choice A rationale Hypoglycemia occurs when blood glucose levels fall below 70 mg/dL, and a level of 42 mg/dL is critically low. This client exhibits classic neuroglycopenic symptoms, including confusion, drowsiness, and irritability, alongside adrenergic signs like diaphoresis. Glipizide, a sulfonylurea, stimulates insulin secretion regardless of glucose levels, which often leads to prolonged hypoglycemia in patients with poor oral intake. Her age and reduced intake over two days significantly increased her risk for this specific metabolic crisis. Choice B rationale Diabetic ketoacidosis is characterized by extreme hyperglycemia, typically over 250 mg/dL, along with metabolic acidosis and ketone production. Patients usually present with Kussmaul respirations, a fruity breath odor, and dehydration. This patient’s blood glucose is 42 mg/dL, which is the opposite of the high levels seen in DKA. While confusion can occur in DKA due to acidosis, the low glucose reading and history of glipizide use point directly toward hypoglycemia rather than a state of insulin deficiency. Choice C rationale While confusion and irritability can be signs of a stroke, the rapid onset of symptoms in the presence of a known diabetic taking glipizide makes a metabolic cause more likely. Stroke symptoms are usually focal, such as one-sided weakness or facial drooping, which are not described here. Furthermore, the blood glucose reading of 42 mg/dL is an objective finding that explains her neurological status perfectly. It is standard practice to rule out hypoglycemia before diagnosing a stroke. Choice D rationale Hyperosmolar Hyperglycemic State is a complication of type 2 diabetes marked by severe hyperglycemia, often exceeding 600 mg/dL, and profound dehydration without significant ketosis. This client’s blood glucose of 42 mg/dL is far below the threshold for HHS. While HHS can cause altered mental status and confusion due to high serum osmolality, this patient’s presentation is dominated by the physiological effects of a sugar deficit, not the osmotic diuresis and high sugar levels characteristic of HHS.